Evidence map›Paper›PMID 23776716›Full record

ArticleInternational journal of preventive medicine2013

Stem cell therapy in stroke: a review literature.

Rokhsareh Meamar, Leila Dehghani, Majid Ghasemi, Fariborz Khorvash, Vahid Shaygannejad

Abstract read
In one paragraph

Article in International journal of preventive medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Graphene-based materials for tissue engineering.Advanced drug delivery reviews · 2016
    Review
  11. Article
  12. Review
  13. Developments in intracerebral stem cell grafts.Expert review of neurotherapeutics · 2015
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rokhsareh MeamarIsfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran ; Department of Medical Science, Islamic Azad University, Najafabad Branch, Isfahan, Iran.
Leila Dehghani
Majid Ghasemi
Fariborz Khorvash
Vahid Shaygannejad

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stroke is an important cause of death in the world and disability world-wide especially in developed countries. Following acute phase of stroke, some procedures and medical treatment such as thrombolytic agents has been recommended; nevertheless many patients have enduring deficits. Thus, there is a realistic need to develop treatment strategies for reducing neurological deficits. However, the stem cell (SC) therapy could arrange an alternative intervention for disease modifying therapy. In this article, we present a brief review of different methods of SC therapy in stroke patients and discuss the results with different cell types and routes of administration.

Indexed as

Clinicalstem cellstroketreatmenttrials

Identifiers

PMID23776716
PMCPMC3678210

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.